---
title: "What To Expect From AMN Healthcare Services’s (AMN) Q4 Earnings"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276193315.md"
description: "AMN Healthcare Services will announce its Q4 earnings this Thursday. Last quarter, it beat revenue expectations by 2.7%, reporting $634.5 million, but saw a 7.7% year-on-year decline. Analysts expect a 1.5% revenue decline this quarter to $723.9 million, with adjusted earnings at $0.27 per share. The company has a history of exceeding expectations, but its stock is down 12.4% recently, with an average analyst price target of $20.86 against a current price of $16.45."
datetime: "2026-02-18T03:09:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276193315.md)
  - [en](https://longbridge.com/en/news/276193315.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276193315.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/276193315.md) | [繁體中文](https://longbridge.com/zh-HK/news/276193315.md)


# What To Expect From AMN Healthcare Services’s (AMN) Q4 Earnings

Healthcare staffing company AMN Healthcare Services will be announcing earnings results this Thursday after the bell. Here’s what investors should know.

AMN Healthcare Services beat analysts’ revenue expectations by 2.7% last quarter, reporting revenues of $634.5 million, down 7.7% year on year. It was an exceptional quarter for the company, with a beat of analysts’ EPS estimates and revenue guidance for next quarter exceeding analysts’ expectations.

Is AMN Healthcare Services a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting AMN Healthcare Services’s revenue to decline 1.5% year on year to $723.9 million, improving from the 10.2% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.27 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AMN Healthcare Services has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 2.1% on average.

Looking at AMN Healthcare Services’s peers in the healthcare providers & services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. The Ensign Group delivered year-on-year revenue growth of 25.9%, missing analysts’ expectations by 4.8%, and DaVita reported revenues up 9.9%, topping estimates by 3.2%. The Ensign Group traded up 13.8% following the results while DaVita was also up 21.2%.

Read our full analysis of The Ensign Group’s results here and DaVita’s results here.

The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.5% on average over the last month. AMN Healthcare Services is down 12.4% during the same time and is heading into earnings with an average analyst price target of $20.86 (compared to the current share price of $16.45).

### Related Stocks

- [AMN Healthcare Services, Inc. (AMN.US)](https://longbridge.com/en/quote/AMN.US.md)

## Related News & Research

- [AMN Healthcare Services Inc (NYSE:AMN) Sees Large Growth in Short Interest](https://longbridge.com/en/news/280947994.md)
- [AMN Healthcare Services (NYSE:AMN) Trading Up 5.3% on Analyst Upgrade](https://longbridge.com/en/news/276618939.md)
- [Vitalist to Acquire Somatix, Pushing VitalOS Deeper Into Medical Wearables](https://longbridge.com/en/news/281221945.md)
- [There’s Been A Staggering Number Of Deaths In ICE Custody During Trump’s Second Term](https://longbridge.com/en/news/281293924.md)
- [Curaleaf Sets May 5 Date to Report First-Quarter 2026 Results](https://longbridge.com/en/news/281662806.md)